| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 3.142 | 4.704 | 5.205 | 8.063 | 5.402 | 3.959 | 8.436 | 1.328 | 706 |
| Total Income - EUR | 0 | 3.142 | 4.704 | 5.205 | 8.063 | 6.474 | 3.959 | 8.436 | 1.328 | 706 |
| Total Expenses - EUR | 738 | 3.963 | 4.620 | 5.373 | 5.475 | 5.450 | 6.011 | 488 | 1.555 | 704 |
| Gross Profit/Loss - EUR | -738 | -821 | 84 | -168 | 2.589 | 1.024 | -2.052 | 7.948 | -227 | 2 |
| Net Profit/Loss - EUR | -738 | -884 | 38 | -218 | 2.508 | 979 | -2.052 | 7.883 | -227 | 2 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Genic Comexim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4 | 657 | 764 | 588 | 4.245 | 1.033 | 1.451 | 633 | 341 | 342 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 5 |
| Cash | 4 | 657 | 764 | 588 | 4.245 | 1.033 | 1.451 | 633 | 337 | 337 |
| Shareholders Funds | -12.024 | -12.785 | -12.531 | -12.519 | -9.769 | -8.605 | -10.466 | -2.615 | -2.834 | -2.816 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 12.028 | 13.443 | 13.295 | 13.107 | 14.013 | 9.637 | 11.917 | 3.249 | 3.176 | 3.158 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6831 - 6831" | |||||||||
| CAEN Financial Year |
6831
|
|||||||||
Comments - Genic Comexim Srl